Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Amolyt Pharma

Amolyt Pharma

Series C
Lyon, FranceJan 2023
Healthtech
← Amolyt Pharma
Amount raised
€129M
€129,159,062
Native amount
138,000,000 USD
Stage
Series C
series c
Investors
16

Provenance & confidence

High confidence
Amount
138,000,000 USD
ECB-at-date → €129M · rate 1.0696 on 2023-01-09
High confidence
Source

tech.eu · own

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

16
Andera PartnersATEMCredit Agricole CreationCTI Life SciencesEQT Life SciencesInnobio 2Intermediate Capital GroupKurma PartnersMass General Brigham VenturesNovo HoldingsOrbiMedPontifaxRelyens Innovation Santé/Turenne CapitalSectoral Asset ManagementSofinnova PartnersTekla Capital Investment LLC
Date
Jan 2023
Round type
series c
Amount (EUR)
€129M

Other rounds

same company

This is the company's only recorded round.

Related news